WO2004097036A3 - Optical detector for enzyme activation - Google Patents

Optical detector for enzyme activation Download PDF

Info

Publication number
WO2004097036A3
WO2004097036A3 PCT/US2004/011092 US2004011092W WO2004097036A3 WO 2004097036 A3 WO2004097036 A3 WO 2004097036A3 US 2004011092 W US2004011092 W US 2004011092W WO 2004097036 A3 WO2004097036 A3 WO 2004097036A3
Authority
WO
WIPO (PCT)
Prior art keywords
energy
substrate
wavelength
bodily fluid
enzyme
Prior art date
Application number
PCT/US2004/011092
Other languages
French (fr)
Other versions
WO2004097036A2 (en
Inventor
Orhan Soykan
Maura G Donovan
Amy Elizebeth Thompson
Original Assignee
Medtronic Inc
Orhan Soykan
Maura G Donovan
Amy Elizebeth Thompson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Inc, Orhan Soykan, Maura G Donovan, Amy Elizebeth Thompson filed Critical Medtronic Inc
Priority to DE602004026172T priority Critical patent/DE602004026172D1/en
Priority to EP04760246A priority patent/EP1618367B1/en
Priority to JP2006509891A priority patent/JP2006525804A/en
Priority to CA002523645A priority patent/CA2523645A1/en
Publication of WO2004097036A2 publication Critical patent/WO2004097036A2/en
Publication of WO2004097036A3 publication Critical patent/WO2004097036A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84—Systems specially adapted for particular applications
    • G01N21/85—Investigating moving fluids or granular solids
    • G01N21/8507—Probe photometers, i.e. with optical measuring part dipped into fluid sample
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6408—Fluorescence; Phosphorescence with measurement of decay time, time resolved fluorescence
    • G01N2021/6415—Fluorescence; Phosphorescence with measurement of decay time, time resolved fluorescence with two excitations, e.g. strong pump/probe flash
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
    • G01N2021/6441—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks with two or more labels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/645—Specially adapted constructive features of fluorimeters
    • G01N2021/6484—Optical fibres
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84—Systems specially adapted for particular applications
    • G01N21/85—Investigating moving fluids or granular solids
    • G01N21/8507—Probe photometers, i.e. with optical measuring part dipped into fluid sample
    • G01N2021/8528—Immerged light conductor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Optics & Photonics (AREA)
  • Signal Processing (AREA)
  • General Engineering & Computer Science (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Artificial Intelligence (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Physiology (AREA)

Abstract

Activation of an enzyme in a bodily fluid is detected based on the amount of cleavage of a substrate for the enzyme. The substrate is tagged with two fluorescent dyes - a donor and an acceptor. The tagged substrate is presented to the bodily fluid. A device emits energy at a first wavelength into the bodily fluid, and detects energy at second and third wavelengths emitted by the dyes in response to the energy at the first wavelength. Prior to enzymatic cleavage of the substrate, the acceptor emits energy at the third wavelength in response to energy at the second wavelength received through fluorescent resonant energy transfer (FRET) from the donor. After enzymatic cleavage of the substrate, the donor emits energy at the second wavelength. The device can determine the concentration of activated enzyme within the bodily fluid based on the relative intensities of energy at the second and third wavelengths.
PCT/US2004/011092 2003-04-25 2004-04-09 Optical detector for enzyme activation WO2004097036A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE602004026172T DE602004026172D1 (en) 2003-04-25 2004-04-09 OPTICAL DETECTOR OF ENZYME ACTIVATION
EP04760246A EP1618367B1 (en) 2003-04-25 2004-04-09 Optical detector for enzyme activation
JP2006509891A JP2006525804A (en) 2003-04-25 2004-04-09 Optical detector for enzyme activation.
CA002523645A CA2523645A1 (en) 2003-04-25 2004-04-09 Optical detector for enzyme activation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/423,112 2003-04-25
US10/423,112 US7473548B2 (en) 2003-04-25 2003-04-25 Optical detector for enzyme activation

Publications (2)

Publication Number Publication Date
WO2004097036A2 WO2004097036A2 (en) 2004-11-11
WO2004097036A3 true WO2004097036A3 (en) 2005-04-14

Family

ID=33299029

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/011092 WO2004097036A2 (en) 2003-04-25 2004-04-09 Optical detector for enzyme activation

Country Status (6)

Country Link
US (3) US7473548B2 (en)
EP (1) EP1618367B1 (en)
JP (1) JP2006525804A (en)
CA (1) CA2523645A1 (en)
DE (1) DE602004026172D1 (en)
WO (1) WO2004097036A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473548B2 (en) * 2003-04-25 2009-01-06 Medtronic, Inc. Optical detector for enzyme activation
JP4423421B2 (en) * 2004-12-01 2010-03-03 国立大学法人浜松医科大学 Evanescent catheter system
US7386333B1 (en) * 2005-04-29 2008-06-10 Henryk Birecki Test subject monitoring device
US8126554B2 (en) 2006-05-17 2012-02-28 Cardiac Pacemakers, Inc. Implantable medical device with chemical sensor and related methods
EP2097536B1 (en) * 2006-10-31 2014-07-16 MUSC Foundation For Research Development Systems for in vivo measurement of interstitial biological activity, processes and/or compositions
EP2056114A1 (en) * 2007-10-29 2009-05-06 Koninklijke Philips Electronics N.V. Automatic detection of infectious diseases
US8180421B2 (en) * 2007-12-12 2012-05-15 Kimberly-Clark Worldwide, Inc. Resonance energy transfer based detection of nosocomial infection
WO2010077205A1 (en) * 2009-01-05 2010-07-08 Ge Healthcare Bio-Sciences Corp A system and method for simultaneously obtaining a plurality of images in an imaging system
TWI402501B (en) * 2009-12-09 2013-07-21 Nat Univ Tsing Hua Immunodetection probe and method of immunodection using the same
WO2014164731A1 (en) 2013-03-11 2014-10-09 University Of Utah Research Foundation Sensor systems
US10716500B2 (en) 2015-06-29 2020-07-21 Cardiac Pacemakers, Inc. Systems and methods for normalization of chemical sensor data based on fluid state changes
CN108968976B (en) 2017-05-31 2022-09-13 心脏起搏器股份公司 Implantable medical device with chemical sensor
JP6997222B2 (en) 2017-06-23 2022-01-17 ザ プロクター アンド ギャンブル カンパニー Compositions and Methods for Improving the Appearance of the Skin
CN109381195B (en) 2017-08-10 2023-01-10 心脏起搏器股份公司 Systems and methods including electrolyte sensor fusion
CN109419515B (en) 2017-08-23 2023-03-24 心脏起搏器股份公司 Implantable chemical sensor with staged activation
CN109864746B (en) 2017-12-01 2023-09-29 心脏起搏器股份公司 Multimode analyte sensor for medical devices
CN109864747B (en) 2017-12-05 2023-08-25 心脏起搏器股份公司 Multimode analyte sensor optoelectronic interface
USD962804S1 (en) * 2019-12-02 2022-09-06 Shenzhen Yimu Technology Co., Ltd. Water quality detector
CN111057745B (en) * 2019-12-30 2022-08-12 中国科学院生态环境研究中心 High-throughput screening method for blood toxicity effect of substance

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3701833A1 (en) * 1986-02-03 1987-08-06 Avl Ag Method for the optical determination of a catalytic enzyme activity of a sample, and an arrangement for carrying out the method
EP0233108A1 (en) * 1986-01-24 1987-08-19 ETAT-FRANCAIS représenté par le DELEGUE GENERAL POUR L'ARMEMENT (DPAG) In vivo dosage spectrophotometer
WO1988008992A1 (en) * 1987-05-06 1988-11-17 St&E, Inc. Fiber optic which is an inherent chemical sensor
US5914245A (en) * 1998-04-20 1999-06-22 Kairos Scientific Inc. Solid phase enzyme kinetics screening in microcolonies
WO2000012028A1 (en) * 1998-08-31 2000-03-09 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
WO2002022882A2 (en) * 2000-09-13 2002-03-21 Archemix Corporation Target activated nucleic acid biosensor and methods of using same
US20020188111A1 (en) * 1999-02-18 2002-12-12 Raymond Kenneth N. Phthalamide lanthanide complexes for use as luminescent markers
WO2003062422A1 (en) * 2002-01-22 2003-07-31 Mcmaster University Signalling aptamer complexes

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146029A (en) 1974-04-23 1979-03-27 Ellinwood Jr Everett H Self-powered implanted programmable medication system and method
US4750494A (en) 1981-05-12 1988-06-14 Medtronic, Inc. Automatic implantable fibrillation preventer
US4671288A (en) 1985-06-13 1987-06-09 The Regents Of The University Of California Electrochemical cell sensor for continuous short-term use in tissues and blood
US4890620A (en) 1985-09-20 1990-01-02 The Regents Of The University Of California Two-dimensional diffusion glucose substrate sensing electrode
US5238809A (en) 1986-02-03 1993-08-24 Avl Medical Instruments Ag Method for optical determination of the catalytic enzyme activity and arrangement for implementing this method
US4705503A (en) 1986-02-03 1987-11-10 Regents Of The University Of Minnesota Metabolite sensor including a chemical concentration sensitive flow controller for a drug delivery system
DE3614821A1 (en) 1986-05-02 1987-11-05 Siemens Ag IMPLANTABLE, CALIBRABLE MEASURING DEVICE FOR A BODY SUBSTANCE AND CALIBRATION METHOD
DE3700119A1 (en) 1987-01-03 1988-07-14 Inst Diabetestechnologie Gemei IMPLANTABLE ELECTROCHEMICAL SENSOR
AU2314688A (en) 1987-07-06 1989-01-30 Cytrx Biopool Ltd. Improved assays for t-plasminogen activator and plasminogen activator inhibitor
CA1327838C (en) 1988-06-13 1994-03-15 Fred Zacouto Implantable device to prevent blood clotting disorders
US6040194A (en) * 1989-12-14 2000-03-21 Sensor Technologies, Inc. Methods and device for detecting and quantifying substances in body fluids
US5305742A (en) * 1992-09-02 1994-04-26 Dale Medical Products, Inc. Endotracheal tube holder
AU689777B2 (en) 1993-05-17 1998-04-09 Fortron Bioscience, Inc. Assay for cardiac troponin I
US5605152A (en) * 1994-07-18 1997-02-25 Minimed Inc. Optical glucose sensor
US5556421A (en) * 1995-02-22 1996-09-17 Intermedics, Inc. Implantable medical device with enclosed physiological parameter sensors or telemetry link
US5741657A (en) 1995-03-20 1998-04-21 The Regents Of The University Of California Fluorogenic substrates for β-lactamase and methods of use
ATE281648T1 (en) * 1995-04-18 2004-11-15 Biosite Diagnostics Inc METHOD FOR ASSAYING TROPONIN I AND T AND TROPONIN I AND T COMPLEXES AND SELECTION OF ANTIBODIES FOR USE IN IMMUNOASSAYS
US5795725A (en) * 1995-04-18 1998-08-18 Biosite Diagnostics Incorporated Methods for the assay of troponin I and T and selection of antibodies for use in immunoassays
US5628310A (en) * 1995-05-19 1997-05-13 Joseph R. Lakowicz Method and apparatus to perform trans-cutaneous analyte monitoring
US6002954A (en) * 1995-11-22 1999-12-14 The Regents Of The University Of California Detection of biological molecules using boronate-based chemical amplification and optical sensors
US5814524A (en) 1995-12-14 1998-09-29 Trustees Of Tufts College Optical sensor apparatus for far-field viewing and making optical analytical measurements at remote locations
DE69637553D1 (en) 1995-12-19 2008-07-10 Abbott Lab Device for detecting an analyte and administering a therapeutic substance
DE19548028A1 (en) * 1995-12-21 1997-06-26 Bayer Ag Method for producing a synthetic calibrator for use in sandwich immunoassays, consisting of an antibody against one of the antibodies used in the assay and a sequence of the analyte
DE59712479D1 (en) * 1996-03-21 2005-12-22 Biotronik Gmbh & Co Kg Implantable stimulation electrode
US5914026A (en) 1997-01-06 1999-06-22 Implanted Biosystems Inc. Implantable sensor employing an auxiliary electrode
US6451980B1 (en) 1997-02-26 2002-09-17 Ban-An Khaw Signal enhancement of bispecific antibody-polymer probe for immunoassay use
US5947124A (en) * 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6259937B1 (en) 1997-09-12 2001-07-10 Alfred E. Mann Foundation Implantable substrate sensor
US6081736A (en) 1997-10-20 2000-06-27 Alfred E. Mann Foundation Implantable enzyme-based monitoring systems adapted for long term use
US6119028A (en) 1997-10-20 2000-09-12 Alfred E. Mann Foundation Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces
AU3622699A (en) 1998-05-18 1999-12-06 Link Enterprises Corporation Fibrinopeptides in saliva as indicator of blood coagulation status
GB9814506D0 (en) * 1998-07-03 1998-09-02 Stanley Christopher J Optical sensor for insitu measurement of analytes
CN1309770A (en) 1998-07-31 2001-08-22 华莱士·E·卡罗尔 Method and apparatus for determining anticoagulant therapy factors
AU6385399A (en) 1998-09-08 2000-03-27 Galvani, Ltd. A method and apparatus for preventing clotting during atrial fibrillation
US6178349B1 (en) * 1999-04-15 2001-01-23 Medtronic, Inc. Drug delivery neural stimulation device for treatment of cardiovascular disorders
JP2000333681A (en) * 1999-05-27 2000-12-05 Nec Corp Substrate for protease containing protease-cleaving sequence and expression vector thereof
DE10023923A1 (en) * 1999-06-10 2000-12-14 Aventis Behring Gmbh Method for determining the activity of the factor VII-activating protease from protein solutions
US6350253B1 (en) * 1999-07-19 2002-02-26 I-Flow Corporation Catheter for uniform delivery of medication
CA2403256A1 (en) * 2000-03-17 2001-09-27 Medtronic, Inc. Heart failure monitor quick look summary for patient management systems
US6442413B1 (en) * 2000-05-15 2002-08-27 James H. Silver Implantable sensor
JP2001326037A (en) * 2000-05-16 2001-11-22 Tokai Rika Co Ltd Connector device for printed circuit board
EP1297341A2 (en) * 2000-06-19 2003-04-02 Merck Frosst Canada Inc. Methods of identifying gaba b? receptor subtype-specific agonists
WO2002017777A2 (en) 2000-08-29 2002-03-07 Medtronic, Inc. Medical device systems implemented network scheme for remote patient management
US7125660B2 (en) * 2000-09-13 2006-10-24 Archemix Corp. Nucleic acid sensor molecules and methods of using same
GB0025147D0 (en) * 2000-10-13 2000-11-29 Torsana Diabetes Diagnostics A Optical sensor for in situ measurement of analytes
GB0108052D0 (en) 2001-03-30 2001-05-23 Diametrics Medical Ltd Implantable analyte measuring device
US6694158B2 (en) * 2001-04-11 2004-02-17 Motorola, Inc. System using a portable detection device for detection of an analyte through body tissue
WO2003029823A1 (en) * 2001-08-27 2003-04-10 Irm Llc Combinatorial protease substrate libraries
US6663615B1 (en) 2001-09-04 2003-12-16 The Ohio State University Dual stage microvalve and method of use
US7635841B2 (en) * 2001-12-12 2009-12-22 Micromass Uk Limited Method of mass spectrometry
US20030113934A1 (en) * 2001-12-17 2003-06-19 Sung-Yun Kwon Diagnostic sensing apparatus
US6855556B2 (en) * 2002-01-04 2005-02-15 Becton, Dickinson And Company Binding protein as biosensors
US7108680B2 (en) 2002-03-06 2006-09-19 Codman & Shurtleff, Inc. Closed-loop drug delivery system
US7473548B2 (en) * 2003-04-25 2009-01-06 Medtronic, Inc. Optical detector for enzyme activation

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0233108A1 (en) * 1986-01-24 1987-08-19 ETAT-FRANCAIS représenté par le DELEGUE GENERAL POUR L'ARMEMENT (DPAG) In vivo dosage spectrophotometer
DE3701833A1 (en) * 1986-02-03 1987-08-06 Avl Ag Method for the optical determination of a catalytic enzyme activity of a sample, and an arrangement for carrying out the method
WO1988008992A1 (en) * 1987-05-06 1988-11-17 St&E, Inc. Fiber optic which is an inherent chemical sensor
US5914245A (en) * 1998-04-20 1999-06-22 Kairos Scientific Inc. Solid phase enzyme kinetics screening in microcolonies
WO2000012028A1 (en) * 1998-08-31 2000-03-09 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
US20020188111A1 (en) * 1999-02-18 2002-12-12 Raymond Kenneth N. Phthalamide lanthanide complexes for use as luminescent markers
WO2002022882A2 (en) * 2000-09-13 2002-03-21 Archemix Corporation Target activated nucleic acid biosensor and methods of using same
WO2003062422A1 (en) * 2002-01-22 2003-07-31 Mcmaster University Signalling aptamer complexes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
POTYRAILO R A ET AL: "ADAPTING SELECTED NUCLEIC ACID LIGANDS (APTAMERS) TO BIOSENSORS", ANALYTICAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. COLUMBUS, US, vol. 70, no. 16, 15 August 1998 (1998-08-15), pages 3419 - 3425, XP000784025, ISSN: 0003-2700 *

Also Published As

Publication number Publication date
US20120046642A1 (en) 2012-02-23
WO2004097036A2 (en) 2004-11-11
US7473548B2 (en) 2009-01-06
DE602004026172D1 (en) 2010-05-06
US8003373B2 (en) 2011-08-23
CA2523645A1 (en) 2004-11-11
US20080227083A1 (en) 2008-09-18
EP1618367B1 (en) 2010-03-24
EP1618367A2 (en) 2006-01-25
JP2006525804A (en) 2006-11-16
US8940522B2 (en) 2015-01-27
US20040215134A1 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
WO2004097036A3 (en) Optical detector for enzyme activation
WO2005043157A3 (en) Optical detector of organic analyte
AU2004298540A1 (en) Reagent for detecting an analyte
WO2005094285A3 (en) Percutaneous chemical sensor based on fluorescence resonant energy transfer (fret)
US7489402B2 (en) Optical collection geometries for phase fluorimetry
AU4701200A (en) A method of detecting an analyte using semiconductor nanocrystals
CN1982875A (en) Fluorescence spectroscopy in absorbing media
WO2007054710A3 (en) Microfluidic device
AU2002221848A1 (en) Dye pair for fluorescence resonance energy transfer (fret) measurements
PT1179600E (en) HIBRIDATION MONITORING DURING CPR
GR1004178B (en) Integrated optoelectronic silicon biosensor for the detection of biomolecules labeled with chromophore groups or nanoparticles
WO2006033843A3 (en) Lanthanide-based substrates and methods for determining clostridial toxin activity
WO2006010839A3 (en) Method for improving detection of fluorescence signals during fluorescence resonance energy transfer
WO2003091713A3 (en) System and method of measuring molecular interactions
WO2004038813A3 (en) Semiconductor optical devices
WO2009118570A3 (en) Time-resolved fluorescence energy transfer (tr-fret) assay for detecting exposure to an infectious organism
WO2005116611A3 (en) Flow assay device comprising dry reagent cake
WO2007123967A3 (en) Biosensors and methods for detecting agents
WO2010002976A3 (en) Enzyme-cleavable dye-containing fluor-quencher constructs
CN101187662A (en) Analytical test strip with electroluminescent module
WO2008012705A3 (en) A photodiode for detection within molecular diagnostics
EP2054715A4 (en) System and method of compensating for system delay in analyte analyzation
WO2004062338A8 (en) Method for determining the amount of template nucleic acid present in a sample
BRPI0417380A (en) infrared gas sensor having a communication device and method of communicating the calibration information of an infrared gas sensor
US20060281190A1 (en) Analyte detection using luminescence concentration

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2523645

Country of ref document: CA

Ref document number: 2006509891

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2004760246

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004760246

Country of ref document: EP